Comparison of Two-treadmill Test Protocols to Evaluate Endurance in People With Cancer

Cancer Clinical Trial

Official title:

Comparison of Two-treadmill Test Protocols to Evaluate Endurance in People With Cancer.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01111032
• Other study ID #: Treadmill Comparison
• Status: Completed
• Phase: N/A
• First received: April 26, 2010
• Last updated: September 29, 2013
• Start date: May 2011
• Est. completion date: December 2011

Study information

• Verified date: September 2013
• Source: McMaster University
• Contact: n/a
• Is FDA regulated: No
• Health authority: Canada: Ethics Review Committee
• Study type: Observational

Clinical Trial Summary

During this study the investigators will compare the use of two treadmill tests in people diagnosed with cancer. The STEEP treadmill protocol is often used to evaluate the endurance of people diagnosed with cancer, however, since it is based on step increases in speed or ramp, it may not related to normal function. The new test, which is based on the body response to increased activity has not been used with people with cancer but may provide a better approximation of endurance demands during daily function. Our question is whether the new treadmill test can be used to evaluate aerobic function with people with cancer better than the STEEP treadmill test.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 12
• Est. completion date: December 2011
• Est. primary completion date: October 2011
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 16 Years and older

Eligibility

Inclusion Criteria:

• Participants are required to be adults (age 16 or over),

• Diagnosed with cancer, at any stage of treatment (during or after treatment),

• Able to follow instructions in English, and provide informed consent.

• Participants need to be considered "well" to participate. A "well participant" has been defined as a cancer survivor who is living at home, able to ambulate independently without a gait aid (single point cane is acceptable), has no acute medical conditions, and passes pre-exercise safety screening.

Exclusion Criteria:

• Cancer survivors with metastatic disease.

• Cancer survivors who are defined as unwell.

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Cancer

Locations

Country	Name	City	State
Canada	Hamilton Health Sciences, Henderson Campus	Hamilton	Ontario

Sponsors (2)

Lead Sponsor	Collaborator
Hamilton Health Sciences Corporation	McMaster University

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	STEEP treadmill test	Treadmill test for endurance. Lasts approx 15 min with 45 min recovery	1 hour	No